LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity
Authors:
- Giuseppe BombaciGBGiuseppe Bombaci
- Mayuresh Anant SarangdharMSMayuresh Anant Sarangdhar
- Nicola AndinaNANicola Andina
- Eric Chi-Wang YuEYEric Chi-Wang Yu
- Gillian M MackieGMGillian M Mackie
- Matthew PughMPMatthew Pugh
- Vedat Burak OzanVOVedat Burak Ozan
- Thibaud SpinettiTSThibaud Spinetti
- Cedric HirzelCHCedric Hirzel
Open Access
- 7 March 2022
- journal article
- research article
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 5 (6) , e202101226
Abstract
Inflammasomes are cytosolic innate immune sensors of pathogen infection and cellular damage that induce caspase-1–mediated inflammation upon activation. Although inflammation is protective, uncontrolled excessive inflammation can cause inflammatory diseases and can be detrimental, such as in coronavirus disease (COVID-19). However, the underlying mechanisms that control inflammasome activation are incompletely understood. Here we report that the leucine-rich repeat (LRR) protein ribonuclease inhibitor (RNH1), which shares homology with LRRs of NLRP (nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain containing) proteins, attenuates inflammasome activation. Deletion of RNH1 in macrophages increases interleukin (IL)-1β production and caspase-1 activation in response to inflammasome stimulation. Mechanistically, RNH1 decreases pro-IL-1β expression and induces proteasome-mediated caspase-1 degradation. Corroborating this, mouse models of monosodium urate (MSU)-induced peritonitis and lipopolysaccharide (LPS)-induced endotoxemia, which are dependent on caspase-1, respectively, show increased neutrophil infiltration and lethality in Rnh1−/− mice compared with wild-type mice. Furthermore, RNH1 protein levels were negatively related with disease severity and inflammation in hospitalized COVID-19 patients. We propose that RNH1 is a new inflammasome regulator with relevance to COVID-19 severity.Keywords
Funding Information
- Swiss National Science Foundation (PP00P3_157486, PP00P3_183721, PP00P3_190073)
This publication has 59 references indexed in Scilit:
- Activation and regulation of the inflammasomesNature Reviews Immunology, 2013
- MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and UsabilityMolecular Biology and Evolution, 2013
- Caspase‐1‐induced pyroptotic cell deathImmunological Reviews, 2011
- Differential Requirement for Caspase-1 Autoproteolysis in Pathogen-Induced Cell Death and Cytokine ProcessingCell Host & Microbe, 2010
- Human leucine-rich repeat proteins: a genome-wide bioinformatic categorization and functional analysis in innate immunityProceedings of the National Academy of Sciences, 2010
- The InflammasomesCell, 2010
- Ribonuclease Inhibitor Regulates Neovascularization by Human AngiogeninBiochemistry, 2009
- Angiogenin cleaves tRNA and promotes stress-induced translational repressionJournal of Cell Biology, 2009
- Flightless-I regulates proinflammatory caspases by selectively modulating intracellular localization and caspase activityJournal of Cell Biology, 2008
- Inducible Gene Targeting in MiceScience, 1995